AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode

RecruitingNAAges 18 Years - anyAllEmobot
💬

In plain words

What the trial is, and whether it could suit you

The aim of this clinical investigation is to find out whether the EMOCARE emotional monitoring software provides consistent results compared with the tools available for assessing the emotional state of patients suffering from mild to moderately severe depressive episod. It will also provide information on how patients feel about the use of passive monitoring software (without the active involvement of patient). The main questions it aims to answer are as follows: Does EMOCARE provide consistent results compared with tools already used in current practice? What are the medical problems encountered by participants when using EMOCARE? The researchers will compare EMCOCARE to various questionnaires usually used in the management of patients suffering from depression (PHQ-9, MADRS, GAD-7, BDI-II, EQ-5D-5L). Participants who agree to take part in the study, during a selection visit, will b

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patient of both sexes aged 18 or over. * Outpatient with unipolar depression (regardless of the time of the episode) (major depressive disorder). * Patient with an episode of major depression supported by PHQ-9 score greater than or equal to 5. * Patient with an episode of major depression supported by MADRS score greater than or equal to 7. * Patient accustomed to regular use of a smartphone and/or computer * Patient who, in the opinion of the investigator, will comply with the requirements of the protocol. * Patient affiliated to a social security scheme or beneficiary of such a scheme. * Patient who has received full information about how the clinical investigation shall be conducted and has signed an informed consent form. * Patient who reads and understands French. * Patient who has undergone clinical screening adapted to the clinical investigation. Exclusion Criteria: * Patient treated with antipsychotic drugs. * Patient with an unstable pathology that could interfere with the study. * Patient unable to communicate or cooperate with the investigator due to a low mental level, language difficulties or impaired cerebral function. * Patient with an active suicidal tendency or patient who has had a suicidal episode in the last 6 months * Patients with borderline personality disorders. * Patient with a contra-indication to the product(s) under evaluation. * Woman of childbearing age without effective contraception. * Pregnant woman, birthing or breastfeeding mother * Minor (not emancipated) * Incapacitated person
💊

What it tests

  • EMOCARE software
📍

Where

11 sites
Private psychiatric practice
Agen, France
Private psychiatric pratice
Caen, France
Centre Psychothérapique de Nancy
Laxou, France
Private psychiatric practice
Maxéville, France
Private psychiatric practice
Nantes, France
Centre Hospitalier Universitaire de Nantes
Nantes, France
Private psychiatric practice
Paris, France
Private psychiatric practice
Reims, France

…and 3 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy